EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug - NeuroSense Therapeutics ( NASDAQ:NRSN )

3 weeks ago

NeuroSense Therapeutics Ltd. NRSN on Wednesday said it is currently in advanced discussions with several multi-billion-dollar pharmaceutical companies regarding a potential strategic partnership to develop and commercialize its lead drug candidate, PrimeC, for Amyotrophic Lateral Sclerosis ( ALS ...

Ticker	Sentiment	Impact
NRSN	Somewhat Bullish	40 %